By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could ...

Please provide your email address to receive an email when new articles are posted on . Data GLP-1s may have benefits beyond glycemic control, weight loss and CVD prevention. Alzheimer's disease, ...

Recently, GLP-1s like Ozempic and Mounjaro have gained attention for weight loss benefits, leading to increased use among individuals seeking to shed pounds. With GLP-1s’ rising popularity, questions ...

Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...

From a clinical standpoint, GLP-1s are not considered addictive in the traditional sense. Ozempic, Mounjaro, and other GLP-1s do not act on the brain’s reward pathways in the same way addictive ...